Catherine Herbert
Psychiatric/Mental Health · Monterey, CANPI 1851805170
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 265 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 39.5% of the total. Reporting peaked in 2021 at $3,692 and has fallen 98.0% since, to $74 in 2025. Among psychiatric/mental health clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 265 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$797
- Sunovion Pharmaceuticals Inc.$501
- Teva Pharmaceuticals USA, Inc.$364
- Takeda Pharmaceuticals U.S.A., Inc.$196
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$184
- plus $795 from 10 others
What the payments were for
- Food & beverage$4,64499%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 91 | $1,853 |
| Johnson & Johnson | 60 | $797 |
| Sunovion Pharmaceuticals Inc. | 28 | $501 |
| Teva Pharmaceuticals USA, Inc. | 19 | $364 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $196 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $184 |
| Eisai Inc. | 12 | $155 |
| Otsuka America Pharmaceutical, Inc. | 14 | $137 |
| Vanda Pharmaceuticals Inc. | 1 | $119 |
| Alkermes, Inc. | 6 | $117 |
| Merck | 4 | $78 |
| Lundbeck LLC | 3 | $56 |
| Avanir Pharmaceuticals, Inc. | 2 | $48 |
| Boston Scientific | 2 | $39 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$330
- INVEGA SUSTENNA$125
- Fanapt$119
- AUSTEDO$109
How this compares
$4,691 in reported general payments places this provider in the 90th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in Monterey
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
- Jonathan LlamasPasadena$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.